Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lethagen

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Thrombosis Research|April 18, 2006
Clinical experience of prophylactic treatment in von Willebrand diseaseStefan Lethagen
Seminars in Thrombosis and Hemostasis|March 18, 2003
Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safetyStefan Lethagen
Ugeskrift for Laeger|March 17, 2009
[Heparin-induced thrombocytopenia]Christina Christoffersen, Stefan Lethagen, Jens Peter Gøtze
Ugeskrift for Laeger|July 15, 2005
[Treatment of uncontrollable, life-threatening hemorrhage]Jakob Stensballe, Stefan Lethagen, Pär Ingemar Johansson
Thrombosis and Haemostasis|September 28, 2002
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X)Stefan Lethagen, Christina Isaksson, Charlotta Schaedel, et al.
Pharmacology & Toxicology|May 20, 2003
Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failureHana Ruzicka, Sven Björkman, Stefan Lethagen, et al.
Plos One|February 2, 2018
Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 15, 2006
Bleeding disorders among young women: a population-based prevalence studyBritt Friberg, Ann Kristin Ornö, Annika Lindgren, et al.
Annals of Human Genetics|May 4, 2011
Variation in the VWF gene in Swedish patients with type 1 von Willebrand DiseaseAnna M Johansson, Christer Halldén, Torbjörn Säll, et al.
Ugeskrift for Laeger|July 15, 2005
[Rational treatment of uncontrollable, life-threatening hemorrhage with recombinant factor VIIa]Jakob Stensballe, Stefan Lethagen, Freddy Lippert, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Thrombosis Research|April 18, 2006
Clinical experience of prophylactic treatment in von Willebrand diseaseStefan Lethagen
Seminars in Thrombosis and Hemostasis|March 18, 2003
Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safetyStefan Lethagen
Ugeskrift for Laeger|March 17, 2009
[Heparin-induced thrombocytopenia]Christina Christoffersen, Stefan Lethagen, Jens Peter Gøtze
Ugeskrift for Laeger|July 15, 2005
[Treatment of uncontrollable, life-threatening hemorrhage]Jakob Stensballe, Stefan Lethagen, Pär Ingemar Johansson
Thrombosis and Haemostasis|September 28, 2002
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X)Stefan Lethagen, Christina Isaksson, Charlotta Schaedel, et al.
Pharmacology & Toxicology|May 20, 2003
Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failureHana Ruzicka, Sven Björkman, Stefan Lethagen, et al.
Plos One|February 2, 2018
Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 15, 2006
Bleeding disorders among young women: a population-based prevalence studyBritt Friberg, Ann Kristin Ornö, Annika Lindgren, et al.
Annals of Human Genetics|May 4, 2011
Variation in the VWF gene in Swedish patients with type 1 von Willebrand DiseaseAnna M Johansson, Christer Halldén, Torbjörn Säll, et al.
Ugeskrift for Laeger|July 15, 2005
[Rational treatment of uncontrollable, life-threatening hemorrhage with recombinant factor VIIa]Jakob Stensballe, Stefan Lethagen, Freddy Lippert, et al.
Pageof 5